ABSTRACTHepatorenal syndrome (HRS), the extreme manifestation of renal impairment in patients with cirrhosis, is characterized by reduction in […]
Doctors working outside their usual area of practice with limited or no support or guidance on how to […]
The Institute has endorsed the drug for first-line treatment of adults with locally-advanced or EGFR mutation-positive NSCLC
The move follows a green light by the UK’s MHRA
The move adds Trodelvy, a first-in-class antibody-drug conjugate approved to treat triple-negative breast cancer, to the drugmaker’s portfolio
Under the deal the UK and Japan will incorporate functions of the existing EU/Japan Mutual Recognition Agreement for […]
Updated Date: Fri, 04 Sep 2020 00:00:00 EDT
Updated Date: Fri, 04 Sep 2020 00:00:00 EDT
Updated Date: Fri, 04 Sep 2020 00:00:00 EDT
